Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Werba Rubin Papier Wealth Management

Werba Rubin Papier Wealth Management decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 492 shares of the medical equipment provider’s stock after selling 49 shares during the quarter. Werba Rubin Papier Wealth Management’s holdings in Intuitive Surgical were worth $257,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the stock. Bennett Selby Investments LP lifted its stake in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares during the period. LVW Advisors LLC lifted its position in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. boosted its stake in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares in the last quarter. FSM Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC raised its stake in shares of Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 19 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock worth $3,587,582 in the last ninety days. 0.80% of the stock is owned by company insiders.

Intuitive Surgical Trading Up 0.9 %

Shares of NASDAQ ISRG opened at $601.17 on Wednesday. The stock has a 50 day moving average of $561.88 and a 200-day moving average of $522.27. The company has a market capitalization of $214.12 billion, a P/E ratio of 93.79, a P/E/G ratio of 5.74 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Evercore ISI increased their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. UBS Group upped their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.